Full text
PDF![396](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd7f/506606/0ec1739c80b9/brjopthal00341-0036.png)
![397](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd7f/506606/a79217415cef/brjopthal00341-0037.png)
![398](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd7f/506606/ceab79780a10/brjopthal00341-0038.png)
![399](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd7f/506606/f82e136c05ac/brjopthal00341-0039.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BEVERLEY J. K. A rational approach to the treatment of toxoplasmic uveitis. Trans Opthal Soc U K. 1958;78:109–121. [PubMed] [Google Scholar]
- BOGACZ J. Action comparée sur les toxoplasmes de diverses substances synthétiques et de quelques antibiotiques dont la spiramycine. Bull Soc Pathol Exot Filiales. 1954;47(6):903–915. [PubMed] [Google Scholar]
- CANAMUCIO C. J., HALLETT J. W., LEOPOLD I. H. Recurrence of treated toxoplasmic uveitis. Am J Ophthalmol. 1963 May;55:1035–1039. [PubMed] [Google Scholar]
- FAJARDO R. V., FURGIUELE F. P., LEOPOLD I. H. Treatment of toxoplasmosis uveitis. Arch Ophthalmol. 1962 Jun;67:712–720. doi: 10.1001/archopht.1962.00960020712004. [DOI] [PubMed] [Google Scholar]
- GARIN J. P., EYLES D. E. Le traitement de la toxoplasmose expérimentale de la souris par la spiramycine. Presse Med. 1958 May 28;66(42):957–958. [PubMed] [Google Scholar]
- GHOSH M., LEVY P. M., LEOPOLD I. H. THERAPY OF TOXOPLASMOSIS UVEITIS. Am J Ophthalmol. 1965 Jan;59:55–61. doi: 10.1016/0002-9394(65)95020-8. [DOI] [PubMed] [Google Scholar]
- GILES C. L., JACOBS L., MELTON M. L. CHEMOTHERAPY OF EXPERIMENTAL TOXOPLASMOSIS. EVALUATIONOF SPIRAMYCIN ALONE AND IN COMBINATION. Arch Ophthalmol. 1964 Jan;71:119–127. doi: 10.1001/archopht.1964.00970010135021. [DOI] [PubMed] [Google Scholar]
- KAUFMAN H. E., REMINGTON J., MELTON M. L., JACOB S. L. Relative resistance of slow-growing strains of Toxoplasma gondii to pyrimethamine (daraprim). Arch Ophthalmol. 1959 Oct;62:611–615. doi: 10.1001/archopht.1959.04220040073010. [DOI] [PubMed] [Google Scholar]
- KAUFMAN H. E. The penetration of daraprim (pyrimethamine) into the monkey eye. Am J Ophthalmol. 1961 Sep;52:402–404. doi: 10.1016/0002-9394(61)90741-3. [DOI] [PubMed] [Google Scholar]
- TENPAS A., ABRAHAM J. P. HEMATOLOGICAL SIDE-EFFECTS OF PYRIMETHAMINE IN THE TREATMENT OF OCULAR TOXOPLASMOSIS. Am J Med Sci. 1965 Apr;249:448–453. doi: 10.1097/00000441-196504000-00014. [DOI] [PubMed] [Google Scholar]